Abstract
Anthrax lethal factor (LF), mitogen-activated protein kinase kinase (MAPKK), small molecular weight inhibitors, structure-based drug discovery, zinc-metalloprotease.
Keywords: Anthrax lethal factor (LF), mitogen-activated protein kinase kinase (MAPKK), small molecular weight inhibitors, structure-based drug discovery, zinc-metalloprotease
Mini-Reviews in Medicinal Chemistry
Title: Low Molecular Weight Inhibitors of the Protease Anthrax Lethal Factor
Volume: 8 Issue: 3
Author(s): Georgios A. Spyroulias, Georgios A. Dalkas, Athanasios Papakyriakou and Alexios Vlamis-Gardikas
Affiliation:
Keywords: Anthrax lethal factor (LF), mitogen-activated protein kinase kinase (MAPKK), small molecular weight inhibitors, structure-based drug discovery, zinc-metalloprotease
Abstract: Anthrax lethal factor (LF), mitogen-activated protein kinase kinase (MAPKK), small molecular weight inhibitors, structure-based drug discovery, zinc-metalloprotease.
Export Options
About this article
Cite this article as:
Spyroulias A. Georgios, Dalkas A. Georgios, Papakyriakou Athanasios and Vlamis-Gardikas Alexios, Low Molecular Weight Inhibitors of the Protease Anthrax Lethal Factor, Mini-Reviews in Medicinal Chemistry 2008; 8 (3) . https://dx.doi.org/10.2174/138955708783744083
DOI https://dx.doi.org/10.2174/138955708783744083 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Leptin and Vascular Smooth Muscle
Current Vascular Pharmacology Further Vitamin D Analogs
Current Vascular Pharmacology Mesenchymal Stromal Cells: A Promising Cell Source for the Treatment of Inflammatory Cardiomyopathy
Current Pharmaceutical Design PET Imaging of Multidrug Resistance in Tumors Using 18F-Fluoropaclitaxel
Current Topics in Medicinal Chemistry Soluble Epoxide Hydrolase, a Target with Multiple Opportunities for Cardiovascular Drug Discovery
Current Topics in Medicinal Chemistry Coumarins as Potential Anti-drug Resistant Cancer Agents: A Mini Review
Current Topics in Medicinal Chemistry Anti-Oxidative Polyphenolic Compounds of Cocoa
Current Pharmaceutical Biotechnology Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway
Current Topics in Medicinal Chemistry On Sports And Genes
Recent Patents on DNA & Gene Sequences Angiogenesis New Targets for the Development of Anticancer Chemotherapies
Current Pharmaceutical Design Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?
Current Neuropharmacology Natural Flora and Anticancer Regime: Milestones and Roadmap
Anti-Cancer Agents in Medicinal Chemistry Estrogen Receptor Neurobiology and its Potential for Translation into Broad Spectrum Therapeutics for CNS Disorders
Current Molecular Pharmacology PET Tracers for Mapping Adenosine Receptors as Probes for Diagnosis of CNS Disorders
Central Nervous System Agents in Medicinal Chemistry IL-19 as a Potential Therapeutic in Autoimmune and Inflammatory Diseases
Current Pharmaceutical Design Synthesis and Biological Evaluation of Pyrido(2,3-<i>d</i>)pyrimidines
Mini-Reviews in Organic Chemistry Cardiovascular Biology of Interleukin-6
Current Pharmaceutical Design Mesenchymal Stem/Stromal Cells: A New "Cells as Drugs" Paradigm. Efficacy and Critical Aspects in Cell Therapy
Current Pharmaceutical Design Monocyte Dependent Regulation of Autoimmune Inflammation
Current Molecular Medicine The Insulin-Like Growth Factor (IGF) Signaling Pathway: Strategies for Successful Therapeutic Tasks in Cancer Treatment
Current Cancer Therapy Reviews